ERBB2 and cancer: Our immunocytochemistry (ICC) and Western blotting analyses demonstrated strong expression of the HER2 protein in SK-BR3, MDA-MB361, and JIMT1 cancer cells compared to MCF7 cancer cells (Figure 1 and Figure 2).